Demonstration of In Vitro Resurrection of Aged Acetylcholinesterase after Exposure to Organophosphorus Chemical Nerve Agents
作者:Qinggeng Zhuang、Andrew J. Franjesevic、Thomas S. Corrigan、William H. Coldren、Rachel Dicken、Sydney Sillart、Ashley DeYong、Nathan Yoshino、Justin Smith、Stephanie Fabry、Keegan Fitzpatrick、Travis G. Blanton、Jojo Joseph、Ryan J. Yoder、Craig A. McElroy、Özlem Doğan Ekici、Christopher S. Callam、Christopher M. Hadad
DOI:10.1021/acs.jmedchem.7b01620
日期:2018.8.23
reactivators of OP-inhibited AChE are no longer effective. Realkylation of aged AChE may provide a route to reversing aging. We designed and synthesized a library of quinonemethideprecursors (QMPs) as proposed realkylators of aged AChE. Our lead compound (C8) from an in vitro screen successfully resurrected 32.7 and 20.4% of the activity of methylphosphonate-aged and isopropyl phosphate-aged electric-eel AChE
[EN] TETRA- AND PENTASUBSTITUTED BENZIMIDAZOLIUM COMPOUNDS USEFUL IN THE TREATMENT OF RESPIRATORY DISEASES<br/>[FR] COMPOSÉS DE BENZIMIDAZOLIUM TÉTRA ET PENTASUBSTITUÉS, UTILES DANS LE TRAITEMENT DE MALADIES RESPIRATOIRES
申请人:BOEHRINGER INGELHEIM INT
公开号:WO2016113169A1
公开(公告)日:2016-07-21
The present invention relates to compounds of formula (I), or the tautomers or pharmacologically acceptable acid addition salts thereof, wherein R1, R2, R3, R4, X, and Z have one of the meanings as defined in the specification, to the use of compounds of formula (I) as a medicament, to pharmaceutical composition comprising at least one com¬ pound of formula (I), as well as to medicament combinations containing one or more compounds of formula (I).
[EN] HETEROAROMATIC ELECTROPHILES AND METHODS OF USING THEREOF<br/>[FR] ÉLECTROPHILES HÉTÉROAROMATIQUES ET LEURS PROCÉDÉS D'UTILISATION
申请人:OHIO STATE INNOVATION FOUNDATION
公开号:WO2018152329A1
公开(公告)日:2018-08-23
Disclosed herein are compounds, compositions, and methods for reactivating or realkylating aged acetylcholinesterase inhibited by or conjugated to the organophosphorus compound. The organophosphorus compound can be a nerve agent. The acetylcholinesterase can be in the central nerve system (CNS) and/or the peripheral nervous system (PNS) of a subject. Accordingly, methods for ameliorating, diminishing, reversing, treating or preventing the toxic effects of an organophosphorus compound in a subject are provided herein. Methods for prophylactic or therapeutic treatment of exposure to an organophosphorus nerve agent are also provided.
Heteroaromatic electrophiles and methods of using thereof
申请人:OHIO STATE INNOVATION FOUNDATION
公开号:US11492340B2
公开(公告)日:2022-11-08
Disclosed herein are compounds, compositions, and methods for reactivating or realkylating aged acetylcholinesterase inhibited by or conjugated to the organophosphorus compound. The organophosphorus compound can be a nerve agent. The acetylcholinesterase can be in the central nerve system (CNS) and/or the peripheral nervous system (PNS) of a subject. Accordingly, methods for ameliorating, diminishing, reversing, treating or preventing the toxic effects of an organophosphorus compound in a subject are provided herein. Methods for prophylactic or therapeutic treatment of exposure to an organophosphorus nerve agent are also provided.
TETRA- AND PENTASUBSTITUTED BENZIMIDAZOLIUM COMPOUNDS USEFUL IN THE TREATMENT OF RESPIRATORY DISEASES
申请人:Boehringer Ingelheim International GmbH
公开号:US20180002312A1
公开(公告)日:2018-01-04
The present invention relates to compounds of formula (I), or the tautomers or pharmacologically acceptable acid addition salts thereof, wherein R
1
, R
2
, R
3
, R
4
, X, and Z have one of the meanings as defined in the specification, to the use of compounds of formula (I) as a medicament, to pharmaceutical composition comprising at least one compound of formula (I), as well as to medicament combinations containing one or more compounds of formula (I).